# Intrathecal Therapy Versus Standard Care for Severe Cancer Pain

> **NCT07691840** · NA · RECRUITING · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 72 (estimated)

## Conditions studied

- Intrathecal Drug Delivery
- Refractory Cancer Pain
- Conventional Medical Management

## Interventions

- **PROCEDURE:** Intrathecal Drug Delivery
- **DRUG:** Comprehensive Medical Management

## Key facts

- **NCT ID:** NCT07691840
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2029-10-31
- **Final completion:** 2029-10-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691840, "Intrathecal Therapy Versus Standard Care for Severe Cancer Pain". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07691840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*